glp-1 cv outcome trials Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes Systematic Review of Cardiovascular Outcome

The additional benefits of higher doses come primarily from the other two receptors, not from more GLP-1 activity

Continuation of Therapy If a patient is already taking a GLP-1 medication but changes insurance plans , the prior authorization can often be submitted as: Continuation of therapy Helpful documentation may include: current medication and dose duration of therapy prior weight or A1C response In some cases, continuation of therapy documentation may help bypass step therapy requirements

[DOI] [PubMed] [Google Scholar] 45.Wilson JM, Lin Y, Luo MJ, Considine G, Cox AL, Bowsman LM, Robins DA, Haupt A, Duffin KL, Ruotolo G

Potential Benefits of the GLP-1 Protocol: Sustainable weight management Improved appetite regulation and reduced cravings Enhanced blood sugar control, benefiting overall health Support for long-term metabolic health and vitality Improved sleep and energy Select a location to see available treatments and pricing

Trapp and Cork (2015)

This effect may be particularly pronounced in patients experiencing rapid weight loss